Expression of functional human C1 inhibitor in COS cells

J Biol Chem. 1988 Aug 25;263(24):11776-9.

Abstract

Full length human C1 inhibitor cDNA was cloned into a vector suitable for transient expression in COS-1 cells. Transfected COS cells secreted an immunoreactive protein of Mr approximately 110,000 that appeared to be functionally equivalent to the plasma-derived protein as established by the following criteria: 1) ability to form sodium dodecyl sulfate-stable complexes with C1s, factor XIIa, and kallikrein; 2) inhibition of C1s-mediated C4 consumption; and 3) susceptibility to inactivation by the nontarget proteinase elastase. Quantitation of secreted recombinant C1 inhibitor by radioimmunoassay indicated that 72 h after transfection the level was approximately 2.2 micrograms/ml. Treatment of transfected cells with tunicamycin resulted in secretion of a protein of Mr approximately 90,000 that was also capable of complex formation with C1s.

MeSH terms

  • Animals
  • Cell Line
  • Complement C1 Inactivator Proteins / genetics*
  • Complement C1 Inactivator Proteins / metabolism
  • Complement C1 Inactivator Proteins / pharmacology
  • Complement C1s / metabolism
  • Complement C4 / metabolism
  • DNA / genetics
  • DNA, Recombinant
  • Electrophoresis, Polyacrylamide Gel
  • Factor XII / metabolism
  • Factor XIIa
  • Haplorhini
  • Humans
  • Immunoassay
  • Kallikreins / metabolism
  • Pancreatic Elastase / pharmacology
  • Recombinant Proteins / genetics*
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Serine Endopeptidases / metabolism
  • Simian virus 40 / genetics
  • Transcription, Genetic
  • Transfection
  • Tunicamycin / pharmacology

Substances

  • Complement C1 Inactivator Proteins
  • Complement C4
  • DNA, Recombinant
  • Recombinant Proteins
  • Tunicamycin
  • Factor XII
  • DNA
  • Kallikreins
  • Serine Endopeptidases
  • Pancreatic Elastase
  • Factor XIIa
  • Complement C1s